期刊文献+

葛根素对人成骨样MG-63细胞OPG、RANKL表达的调节作用

Regulatory effect of puerarin on the expression of OPG and RANKL in human osteoblastic MG-63 cells
原文传递
导出
摘要 【目的】观察葛根素对人成骨样MG-63细胞骨吸收调节因子骨保护素(osteoprotegerin,OPG)、NF-κB激活受体配体(receptor activator of nuclear factor kappa-B ligand,RANKL)表达的调节作用,并初步探讨对其可能的作用机制。【方法】选择兼有两种雌激素受体(estrogen receptor,ER)亚型表达的人成骨样MG-63细胞为研究模型,采用RT-PCR及Western blotting技术,检测OPG/RANKL的mRNA和蛋白的表达水平;采用RNA干扰技术特异性的将ERα、ERβ基因沉默,从而检测葛根素是否通过ERα和ERβ介导发挥作用。【结果】葛根素可显著上调成骨细胞OPG mRNA和蛋白的表达水平,下调RANKL mRNA和蛋白的表达水平。ER阻断剂ICI 182,780可完全阻断葛根素诱导的OPG表达水平增高,部分阻断了葛根素对RANKL表达的下调作用。利用RNA干扰技术构建ERα/ERβ不同表达状态的细胞株,结果显示:与对照组MG-63+葛根素、对照组MG-63/scrambled shRNA+葛根素相比,葛根素对MG-63/ERαshRNA和MG-63/ERβshRNA细胞OPG、RANKL的mRNA和蛋白水平的影响无显著性差异。【结论】葛根素显著上调MG-63细胞中OPG的mRNA及蛋白表达水平,同时下调RANKL的mRNA及蛋白表达水平,该作用可经ERα和ERβ共同介导。 【Objective】To observe the regulatory effect of puerarin on the expression of bone-absorption regulatory factors osteoprotegerin(OPG)and receptor activator of NF-κB ligand(RANKL)in human osteoblastic MG-63 cells,and preliminarily explore the possible mechanism.【Methods】Human osteoblastic MG-63 cells containing two estrogen receptor(ER)isoforms were chosen as the suitable model for this study.RT-PCR,Western blot analysis and RNA interference technology were respectively used to detect the effect of puerarin on the mRNA and protein expression of OPG and RANKL in MG-63 cells and explore the relevant mechanisms.【Results】Puerarin could significantly increase the mRNA and protein expression levels of OPG,but decrease the mRNA and protein expression levels of RANKL in osteoblastic MG-63 cells.The ER blocker ICI 182,780 completely blocked the increase of puerarininduced OPG expression level and partially blocked the down-regulation of puerarin on RANKL expression.RNA interference technology suggested the regulatory effect of puerarin on OPG and RANKL expression were mediated by ERαand ERβ.【Conclusion】Puerarin significantly up-regulates OPG expression but down-regulates RANKL expression in osteoblastic MG-63 cells.These effects are mediated via ERαand ERβpathways.
作者 祁琳 李新敏 张玲玲 王越 黄宗堂 王卫国 QI Lin;LI Xin-min;ZHANG Ling-ling;WANG Yue;HUANG Zong-tang;WANG Wei-guo(Department of Pharmacy,Characteristic Medical Center of PAP,Tianjin 300162,China)
出处 《武警后勤学院学报(医学版)》 CAS 2020年第2期1-6,共6页 Journal of Logistics University of PAP(Medical Sciences)
基金 国家自然科学基金项目(81572852) 天津市自然科学基金项目(18JCZDJC33200)
关键词 葛根素 骨吸收调节因子骨保护素 NF-κB激活受体配体 雌激素受体 Puerarin Osteoprotegerin Receptor activator of NF-κB ligand Estrogen receptor
  • 相关文献

参考文献4

二级参考文献49

  • 1Pan Wei,Ming Liu,Yan Chen,De-Cai Chen.Systematic review of soy isoflavone supplements on osteoporosis in women[J].Asian Pacific Journal of Tropical Medicine,2012,5(3):243-248. 被引量:13
  • 2骆凯,闫福华,陈凌,郑碧琼,陈玉玲.绝经后骨质疏松大鼠实验性牙周炎动物模型研究[J].口腔医学研究,2006,22(2):130-132. 被引量:16
  • 3Inzerillo AM, Zaidi M. Osteoporosis: trends and intervention. Mt Sinai J Med 2002; 69: 220-231.
  • 4Beral V, Bull D, Reeves G. Endometrial cancer and hormone replacement therapy in the Million Women Study. Lancet 2005; 365: 1543-1551.
  • 5Price KR, Fenwick GR. Naturally occurring oestrogens in foods-a review. Food Addit Contam 1985; 2: 73-106.
  • 6Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isoflavones, and breast cancer risk in Japan. J Nat! Cancer Inst2003; 95: 906-913.
  • 7Messina MJ. Soy foods and soy isoflavones and menopausal health. Nutr Clin Care 2002; 5: 272-282.
  • 8Hazenberg Jo. Taylor D, Lee TC. The role of osteocytes and bone microstructure in preventing osteoporotic fractures. Osteoporos Int 2007; 18: 1-8.
  • 9Huber C, Collishaw S, Mosley JR, Reeve J, Noble BS. Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance. Calcif Tissue lnt 2007; 81: 139-144.
  • 10Mann V, Huber C, Kogianni G, Collins F, Noble .:>. The antioxidant effect of estrogen and selective estrogen receptor modulators in the inhibition of osteocyte apoptosis in vitro. Bone 2007; 40: 674-684.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部